{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:03:51Z","timestamp":1790046231091,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","geriatriconcology.net","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jgo.2018.03.020","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T23:19:40Z","timestamp":1523920780000},"page":"507-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients"],"prefix":"10.1016","volume":"9","author":[{"given":"Marco","family":"Racioppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Di Gianfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PierFrancesco","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2018.03.020_bb0005","series-title":"SEER stat fact sheets: bladder","author":"Surveillance Research Program","year":"2013"},{"key":"10.1016\/j.jgo.2018.03.020_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgo.2014.11.006","article-title":"How I treat bladder cancer in elderly patients","volume":"6","author":"Galsky","year":"2015","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2018.03.020_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.eururo.2016.10.008","article-title":"Global burden of urologic cancers, 1990\u20132013","volume":"71","author":"Dy","year":"2017","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.jgo.2018.03.020_bb0020","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jgo.2018.03.020_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.seminoncol.2003.12.024","article-title":"Cancer in older persons: an international issue in an aging world","volume":"31","author":"Yancik","year":"2004","journal-title":"Semin Oncol"},{"issue":"25","key":"10.1016\/j.jgo.2018.03.020_bb0030","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0035","series-title":"Epidemiology of bladder cancer in Europe","author":"Crocetti","year":"2016"},{"issue":"3","key":"10.1016\/j.jgo.2018.03.020_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jgo.2018.03.020_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1464-410X.2012.11754.x","article-title":"Bacillus Calmette-Guerin immunotherapy for genitourinary cancer","volume":"112","author":"Gandhi","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jgo.2018.03.020_bb0050","first-page":"157","article-title":"Managing the adverse events of intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"7","author":"Decaestecker","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bju.13474","volume":"118","author":"Oddens","year":"2016","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.jgo.2018.03.020_bb0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.eururo.2014.05.033","article-title":"The effect of age on the efficacy of maintenance Bacillus Calmette-Gu\u00e9rin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911","volume":"66","author":"Oddens","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.jgo.2018.03.020_bb0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"Sylvester","year":"2010","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.jgo.2018.03.020_bb0070","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.6004\/jnccn.2016.0131","article-title":"NCCN guidelines insights: bladder cancer version 2.2016","volume":"14","author":"Clark","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.jgo.2018.03.020_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JOP.2011.000480","article-title":"Adjuvant intravesical Bacillus Calmette-Gu\u00e9rin therapy and survival among elderly patients with non\u2013muscle-invasive bladder","volume":"9","author":"Spencer","year":"2013","journal-title":"Cancer J Oncol Pract"},{"issue":"27","key":"10.1016\/j.jgo.2018.03.020_bb0080","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Under-representation of patients 65\u202fyears of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2018.03.020_bb0085","first-page":"939","article-title":"Bladder cancer in the elderly patient: challenges and solutions","volume":"10","author":"Guancial","year":"2015","journal-title":"Clin Interv Aging"},{"issue":"6","key":"10.1016\/j.jgo.2018.03.020_bb0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.urolonc.2009.07.020","article-title":"Bladder Cancer in the Elderly","volume":"27","author":"Shariat","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0095","series-title":"TNM classification of malignant tumors. UICC International Union Against Cancer","author":"Brierley","year":"2017"},{"key":"10.1016\/j.jgo.2018.03.020_bb0100","series-title":"WHO classification of tumours of the urinary system and male genital organs","author":"Moch","year":"2016"},{"issue":"2","key":"10.1016\/j.jgo.2018.03.020_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0019-5049.79879","article-title":"American society of anaesthesiologists physical status classification","volume":"55","author":"Daabiss","year":"2011","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.jgo.2018.03.020_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.jgo.2018.03.020_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.jgo.2018.03.020_bb0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.06870909","article-title":"Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body sizeclin","volume":"5","author":"Michels","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0130","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S1470-2045(14)70018-X","article-title":"Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology","volume":"15","author":"Droz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0135","author":"National Cancer Institute"},{"key":"10.1016\/j.jgo.2018.03.020_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jgo.2018.03.020_bb0145","series-title":"Biometry: the principles and practice of statistics in biological research","author":"Sokal","year":"1995"},{"key":"10.1016\/j.jgo.2018.03.020_bb0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fpubh.2017.00101","article-title":"Cancer immunoprevention and public health","volume":"5","author":"Singh","year":"2017","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.jgo.2018.03.020_bb0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2009.06.002","article-title":"The role of immunity in elderly cancer","volume":"74","author":"Malaguarnera","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.jgo.2018.03.020_bb0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI64096","article-title":"Causes, con-sequences, and reversal of immune system aging","volume":"123","author":"Montecino-Rodriguez","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jgo.2018.03.020_bb0165","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1007\/s11357-014-9729-x","article-title":"Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease","volume":"36","author":"Bueno","year":"2014","journal-title":"Age (Dordr)"},{"issue":"4","key":"10.1016\/j.jgo.2018.03.020_bb0170","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.urology.2011.04.070","article-title":"Diminished efficacy of Bacille Calmette-Gu\u00e9rin among elderly patients with nonmuscle invasive bladder cancer","volume":"78","author":"Margel","year":"2011","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.jgo.2018.03.020_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with bacille Calmette-Gu\u00e9rin therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jgo.2018.03.020_bb0180","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jgo.2018.03.020_bb0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jjco\/hyq241","article-title":"Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy?","volume":"41","author":"Yuge","year":"2011","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2018.03.020_bb0190","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bjc.2013.106","article-title":"Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients","volume":"108","author":"Noon","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jgo.2018.03.020_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2012.08.064","article-title":"Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer","volume":"63","author":"Thomas","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0200","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.juro.2006.03.066","article-title":"Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients","volume":"176","author":"Yossepowitch","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","article-title":"Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guerin therapy","volume":"26","author":"Heiner","year":"2008","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2018.03.020_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1532-5415.2010.03210.x","article-title":"Factors affecting recovery of functional status in older adults after cancer surgery","volume":"59","author":"Van Cleave","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jgo.2018.03.020_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.critrevonc.2009.09.005","article-title":"Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults","volume":"73","author":"Droz","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.jgo.2018.03.020_bb0220","first-page":"e150","article-title":"Management of prostate cancer in elderly patients: recommendations of a task force of the international society of geriatric oncology","volume":"71","author":"Droz","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1532-5415.2003.51465.x","article-title":"The Mini-Cog as a screen for dementia: validation in a population-based sample","volume":"51","author":"Borson","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2018.03.020_bb0230","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations","volume":"26","author":"Decoster","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0235","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jgo.2018.03.020_bb0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.jgo.2018.03.020_bb0245","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1532-5415.1968.tb02103.x","article-title":"Cumulative illness rating scale","volume":"16","author":"Linn","year":"1968","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.jgo.2018.03.020_bb0250","first-page":"15","article-title":"Mini-nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients","volume":"4","author":"Guigoz","year":"1994","journal-title":"Facts Res Gerontol"},{"key":"10.1016\/j.jgo.2018.03.020_bb0255","author":"American Cancer Society"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818301334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818301334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T14:07:23Z","timestamp":1535119643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406818301334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1879406818301334"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2018.03.020","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2018.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}